ResearcherHokkaido UniversityActive in the last 2 years
Kyoko Hida
Matched on ORCID iD 0000-0002-7968-6062; OpenAlex author ID A5061967603, A5112008569. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 3
- Biglycan Secreted by Tumor Stromal Cells Is a Predictive Marker for the Early Recurrence of Pancreatic Cancer. Last author DOI 10.1111/pin.70175↗
- A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control study. Co-author DOI 10.1016/j.eclinm.2024.102936↗
- Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target. Co-author DOI 10.1158/1535-7163.mct-19-0491↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hironori Tanaka · 1 shared paper, 2026 · strength 0.27
- Toshimichi Asano · 2 shared papers, 2020–2024 · strength 0.24
- Satoshi Hirano · 2 shared papers, 2020–2024 · strength 0.24
- Tomoya Kawase · 1 shared paper, 2024 · strength 0.15
- Shogo Baba · 1 shared paper, 2024 · strength 0.15
- Yasutaka Kato · 1 shared paper, 2024 · strength 0.15
- Tomoyuki Satake · 1 shared paper, 2024 · strength 0.15
- Johji Imura · 1 shared paper, 2024 · strength 0.15
- Hiroshi Kurahara · 1 shared paper, 2024 · strength 0.15
- Hideyuki Oi · 1 shared paper, 2024 · strength 0.15
- Hiroshi Nishihara · 1 shared paper, 2024 · strength 0.15
- Koji Yoshida · 1 shared paper, 2024 · strength 0.15
- Kazuho Inoko · 1 shared paper, 2020 · strength 0.08
- Toshiaki Shichinohe · 1 shared paper, 2020 · strength 0.08
- Yoshitsugu Nakanishi · 1 shared paper, 2020 · strength 0.08
- Toshihiro Kushibiki · 1 shared paper, 2020 · strength 0.08
- Takahiro Tsuchikawa · 1 shared paper, 2020 · strength 0.08
- Toru Nakamura · 1 shared paper, 2020 · strength 0.08
- Shinya Tanaka · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.